Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 6/2024

24-01-2024 | Esophageal Cancer | ASO Author Reflections

ASO Author Reflections: Significance of Skeletal Muscle Loss After Neoadjuvant Chemoradiation for Esophageal Cancer

Authors: Xin Xiao, MD, Pin-Hao Fang, MD, Jian-Feng Zhou, MD, Yong Yuan, MD, PhD

Published in: Annals of Surgical Oncology | Issue 6/2024

Login to get access

Excerpt

Many studies and meta-analyses had proven that esophageal cancer patients with sarcopenia had a disadvantage on surgical morbidity and survival benefit.1,2 Sarcopenia, a time-specific body composition, could be diagnosed through assessing skeletal muscle index (SMI). However, the addition of neoadjuvant therapy might contribute to body compositional changes and influence patients’ nutritional status for locally advanced esophageal cancer.3,4 It was more important to investigate the changes in skeletal muscle index during neoadjuvant therapy, instead of solely focusing on sarcopenia status at presentation. …
Literature
1.
Fang P, Zhou J, Xiao X, et al. The prognostic value of sarcopenia in oesophageal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;14(1):3–16.CrossRefPubMedPubMedCentral
2.
Jogiat UM, Sasewich H, Turner SR, et al. Sarcopenia determined by skeletal muscle index predicts overall survival, disease-free survival, and postoperative complications in resectable esophageal cancer: a systematic review and meta-analysis. Ann Surg. 2022;276(5):e311–8.CrossRefPubMed
3.
Awad S, Tan BH, Cui H, et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr. 2012;31(1):74–7.CrossRefPubMed
4.
Yip C, Goh V, Davies A, et al. Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. Eur Radiol. 2014;24(5):998–1005.CrossRefPubMed
5.
Metadata
Title
ASO Author Reflections: Significance of Skeletal Muscle Loss After Neoadjuvant Chemoradiation for Esophageal Cancer
Authors
Xin Xiao, MD
Pin-Hao Fang, MD
Jian-Feng Zhou, MD
Yong Yuan, MD, PhD
Publication date
24-01-2024
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 6/2024
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-024-14968-9

Other articles of this Issue 6/2024

Annals of Surgical Oncology 6/2024 Go to the issue

Sarcoma

High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma

Peritoneal Surface Malignancy

Optimizing Postoperative Pain Management After Cytoreductive Surgery: Time to Break Old Habits and Usher in More Interdisciplinary Collaboration

Reconstructive Oncology

Distribution of Perigastric Station 4d Lymph Nodes in Vascularized Gastroepiploic Lymph Node Transfer: An Anatomic Study and Case Series

Urologic Oncology

Risk Factors of Open Surgery Conversion in Laparoscopic Partial Nephrectomy to Achieve Nephron Sparing

Pancreatic Tumors

Preoperative Fistula Risk Prediction Using Computed Tomography Image Before Pancreatoduodenectomy

ASO Visual Abstract

ASO Visual Abstract: Pancreatectomy Induces Cancer-Promoting Neutrophil Extracellular Traps